Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
54,120,723
-
Share change
-
-1,288,584
-
Total reported value
-
$6,923,891,307
-
Put/Call ratio
-
119%
-
Price per share
-
$127.94
-
Number of holders
-
250
-
Value change
-
-$150,205,442
-
Number of buys
-
115
-
Number of sells
-
111
Institutional Holders of ACCELERON PHARMA INC - COMMON STOCK (XLRN) as of Q4 2020
As of 31 Dec 2020,
ACCELERON PHARMA INC - COMMON STOCK (XLRN) was held by
250 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,120,723 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FMR LLC, BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, ALKEON CAPITAL MANAGEMENT LLC, Avoro Capital Advisors LLC, Artal Group S.A., and WELLINGTON MANAGEMENT GROUP LLP.
This page lists
250
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.